LY N001
Alternative Names: LY-N001Latest Information Update: 06 Jan 2024
At a glance
- Originator Lingyi Biotech
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Neurodegenerative disorders
Most Recent Events
- 20 Dec 2023 Early research in Neurodegenerative disorders in China (Parenteral), prior to December 2023 (Lingyi Biotech pipeline, December 2023)